Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFBW
3251
DELISTED
FFBW, Inc. Common Stock
FFBW
| $150K | ﹤0.01% |
+15,236
| New | +$150K |
|
3252
Kopin
KOPN
$371M
| $149K | ﹤0.01% |
371,200
+308,400
| +491% | +$124K |
|
|
CURO
3253
DELISTED
CURO Group Holdings Corp.
CURO
| $149K | ﹤0.01% |
12,200
-7,400
| -38% | -$90.4K |
|
|
FTSI
3254
DELISTED
FTS International, Inc. Common Stock
FTSI
| $149K | ﹤0.01% |
7,175
+4,220
| +143% | +$87.6K |
|
|
PROF
3255
Profound Medical
PROF
$123M
| $147K | ﹤0.01% |
+12,900
| New | +$147K |
|
3256
China SXT Pharmaceuticals
SXTC
$172M
| $146K | ﹤0.01% |
11
+10
| +1,000% | +$133K |
|
|
MORL
3257
DELISTED
ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN
MORL
| $146K | ﹤0.01% |
+10,200
| New | +$146K |
|
3258
Vista Gold
VGZ
$179M
| $138K | ﹤0.01% |
190,300
+82,499
| +77% | +$59.8K |
|
3259
Imunon
IMNN
$14.7M
| $136K | ﹤0.01% |
407
+321
| +373% | +$107K |
|
3260
NovaBay Pharmaceuticals
NBY
$13.4M
| $136K | ﹤0.01% |
174
-110
| -39% | -$86K |
|
3261
Mega Matrix
MPU
$82.4M
| $134K | ﹤0.01% |
148,500
-4,500
| -3% | -$4.06K |
|
3262
CPI Card Group
PMTS
$167M
| $134K | ﹤0.01% |
148,882
+21,303
| +17% | +$19.2K |
|
3263
Xtant Medical Holdings
XTNT
$81.4M
| $134K | ﹤0.01% |
84,061
+3,300
| +4% | +$5.26K |
|
|
SCNI
3264
Scinai Immunotherapeutics
SCNI
$1.51M
| $133K | ﹤0.01% |
+143
| New | +$133K |
|
|
ZN
3265
DELISTED
Zion Oil & Gas, Inc.
ZN
| $133K | ﹤0.01% |
769,100
+687,391
| +841% | +$119K |
|
3266
Eterna Therapeutics
ERNA
$9.67M
| $131K | ﹤0.01% |
99
+3
| +3% | +$3.97K |
|
|
BIOC
3267
DELISTED
Biocept, Inc.
BIOC
| $131K | ﹤0.01% |
+1,526
| New | +$131K |
|
|
UNAM
3268
DELISTED
Unico American Corp
UNAM
| $130K | ﹤0.01% |
20,600
+600
| +3% | +$3.79K |
|
|
VTNR
3269
DELISTED
Vertex Energy, Inc
VTNR
| $129K | ﹤0.01% |
83,906
+67,393
| +408% | +$104K |
|
|
FORK
3270
DELISTED
Fuling Global Inc
FORK
| $129K | ﹤0.01% |
53,795
-28,700
| -35% | -$68.8K |
|
3271
Jerash Holdings
JRSH
$43.9M
| $128K | ﹤0.01% |
21,888
+6,786
| +45% | +$39.7K |
|
3272
Milestone Scientific
MLSS
$50.1M
| $128K | ﹤0.01% |
+92,271
| New | +$128K |
|
3273
Verastem
VSTM
$611M
| $126K | ﹤0.01% |
+7,867
| New | +$126K |
|
|
TCS
3274
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $126K | ﹤0.01% |
1,984
-24,033
| -92% | -$1.53M |
|
|
ETTX
3275
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $126K | ﹤0.01% |
25,300
+7,600
| +43% | +$37.9K |
|